AU3471995A - Pharmaceutical formulations comprising clavulanic acid or derivatives and an organic acid or salt - Google Patents

Pharmaceutical formulations comprising clavulanic acid or derivatives and an organic acid or salt

Info

Publication number
AU3471995A
AU3471995A AU34719/95A AU3471995A AU3471995A AU 3471995 A AU3471995 A AU 3471995A AU 34719/95 A AU34719/95 A AU 34719/95A AU 3471995 A AU3471995 A AU 3471995A AU 3471995 A AU3471995 A AU 3471995A
Authority
AU
Australia
Prior art keywords
derivatives
acid
salt
pharmaceutical formulations
organic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34719/95A
Inventor
Patrick John Crowley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9417953A external-priority patent/GB9417953D0/en
Priority claimed from GBGB9503752.9A external-priority patent/GB9503752D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU3471995A publication Critical patent/AU3471995A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
AU34719/95A 1994-09-03 1995-08-21 Pharmaceutical formulations comprising clavulanic acid or derivatives and an organic acid or salt Abandoned AU3471995A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB9417953A GB9417953D0 (en) 1994-09-03 1994-09-03 Pharmaceutical formulations
GB9417953 1994-09-03
GBGB9503752.9A GB9503752D0 (en) 1995-02-24 1995-02-24 Pharmaceutical formulations
GB9503752 1995-02-24
US46044195A 1995-06-02 1995-06-02
US460441 1995-06-02
PCT/EP1995/003322 WO1996007408A1 (en) 1994-09-03 1995-08-21 Pharmaceutical formulations comprising clavulanic acid or derivatives and an organic acid or salt

Publications (1)

Publication Number Publication Date
AU3471995A true AU3471995A (en) 1996-03-27

Family

ID=27267365

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34719/95A Abandoned AU3471995A (en) 1994-09-03 1995-08-21 Pharmaceutical formulations comprising clavulanic acid or derivatives and an organic acid or salt

Country Status (8)

Country Link
EP (1) EP0782443A1 (en)
JP (1) JPH10505595A (en)
AU (1) AU3471995A (en)
DZ (1) DZ1926A1 (en)
IL (1) IL115125A0 (en)
MA (1) MA23663A1 (en)
TR (1) TR199501082A2 (en)
WO (1) WO1996007408A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100495585B1 (en) 1995-09-07 2005-09-09 스미스클라인비이참피이엘시이 Pharmaceutical Formulation
IL131201A (en) * 1997-02-14 2005-06-19 Smithkline Beecham Lab Pharmaceutical formulations comprising amoxycillin and clavulanate
US6706290B1 (en) 1998-07-06 2004-03-16 Olvai E. Kajander Methods for eradication of nanobacteria
AU5029599A (en) * 1998-07-06 2000-01-24 Neva Ciftcioglu Methods for eradication of nanobacteria
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
EP1330236A2 (en) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US8614315B2 (en) * 2009-12-25 2013-12-24 Mahmut Bilgic Cefdinir and cefixime formulations and uses thereof
TR201000688A2 (en) 2010-01-29 2011-08-22 B�Lg�� Mahmut Effervescent formulations containing cefaclor and clavulanic acid as active ingredient.
EP2575782A2 (en) * 2010-06-03 2013-04-10 Mahmut Bilgic Effervescent formulations comprising cephalosporin and clavulanic acid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2861607D1 (en) * 1977-11-26 1982-03-11 Beecham Group Plc Derivatives of clavulanic acid and pharmaceutical compositions containing them
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
EP0680322B1 (en) * 1993-01-22 2000-07-05 Smithkline Beecham Plc Use of clavulanate and an antibacterial compound for the treatment of infections

Also Published As

Publication number Publication date
MA23663A1 (en) 1996-04-01
EP0782443A1 (en) 1997-07-09
IL115125A0 (en) 1995-12-31
DZ1926A1 (en) 2002-02-17
TR199501082A2 (en) 1996-06-21
JPH10505595A (en) 1998-06-02
WO1996007408A1 (en) 1996-03-14

Similar Documents

Publication Publication Date Title
AU2505795A (en) 1-arylpyrimidine derivatives and pharmaceutical use thereof
HK1050992A1 (en) Amoxycillin and clavulanate containing pharmaceutical formulation
IL128600A0 (en) Propionic acid derivatives and pharmaceutical compositions containing them
IL131201A (en) Pharmaceutical formulations comprising amoxycillin and clavulanate
AU6995396A (en) Pharmaceutical formulation
HUP9901437A3 (en) Pharmaceutical formulation, containing amoxycillin and clavulanate
AU2415299A (en) Substituted benzenesulfonamide derivatives and their pharmaceutical use
AU5856898A (en) Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them
HU9502520D0 (en) Pharmaceutical use of substituted 4-phenyl-6-amino-nicotinic acid derivatives
AU5814096A (en) Composition comprising amoxycillin and clavulanic acid
PL345564A1 (en) Pharmaceutical suspension formulation comprising amoxycillin, clavulanic acid and cellulose
AU3471995A (en) Pharmaceutical formulations comprising clavulanic acid or derivatives and an organic acid or salt
AU5647199A (en) Carboxylic acid derivatives and drugs containing the same as the active ingredient
AU5443499A (en) Carboxylic acid derivatives and drugs containing the same as the active ingredient
AU7582696A (en) Pharmaceutical formulation
AU7275894A (en) Imidazolylalkylamine derivative and pharmaceutical composition thereof
AU4123396A (en) Cephem compounds and pharmaceutical use thereof
AU7449198A (en) Phthalimide derivatives and pharmaceutical containing said derivatives
AU3407597A (en) Useful formulations of acid addition salt drugs
AU6120298A (en) 2-peperazinone-1-acetic acid derivatives and their use
AU3363193A (en) Pharmaceutical formulations comprising a clavulanic acid salt and erithromycin derivative
AU6944696A (en) Novel phenylacetic acid derivatives and medicinal composition containing the same
AU6690394A (en) Imidazolylquinoxalinedione derivative and pharmaceutical composition thereof
AU3107497A (en) Asialotrisaccharide moranoline derivatives and drugs
AU2792695A (en) Amino acid derivatives and their use as pesticides